Risultati di ricerca
4 giorni fa · Published. Severe Perioperative Bleeding Management Guideline - 2nd update. Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care. Second update 2022.
17 ore fa · Among patients with high bleeding risk receiving percutaneous coronary intervention (PCI) and treated with a short duration of dual antiplatelet therapy (DAPT), those with cancer have higher rates of clinical events and major bleeding at 1 year compared with patients with high bleeding risk without cancer, according to a study in Circulation: Cardiovascular Interventions.
17 ore fa · Abstract. Ticagrelor is a platelet P2Y 12 receptor inhibitor approved for use in patients with acute coronary syndromes, coronary artery disease, and low‐moderate risk acute ischemic stroke or high‐risk transient ischemic attack. Clinical trials have evaluated the efficacy and safety of ticagrelor on ischemic and bleeding outcomes for ...
1 giorno fa · Fibrinogen replacement therapy is currently recommended for both congenital 6,7 and acquired fibrinogen deficiencies caused by various clinical conditions, including major bleeding and cardiac surgery. 8–10 Transfusion of fresh frozen plasma (FFP), cryoprecipitate, or human fibrinogen concentrate is performed with the aim of replacing fibrinogen. 11,12 However, cryoprecipitate is not ...
4 giorni fa · Background Dieulafoy’s lesion (DL) is a rare and important cause of acute nonvariceal upper gastrointestinal bleeding (ANVUGIB), however, there is a lack of clear guidelines focus on the endoscopic hemostasis treatment for DL. Sclerotherapy, as the ANVUGIB guideline recommended endoscopic hemostasis method, is widely used in clinical practice. The aim of this study is to investigate the ...
1 giorno fa · Huijs et al. (AJOG, 2024) assessed long-term differences in reintervention risk and menstrual blood loss in women with heavy menstrual bleeding treated with a 52-mg levonorgestrel-IUD or radiofrequency nonresectoscopic endometrial ablation; METHODS: Long-term follow-up to a multicenter randomized controlled trial MIRA trial | Netherlands ...
4 giorni fa · During Hemlibra treatment, patients with inhibitors had fewer bleeding episodes in general compared with those without inhibitors (mean ABR of 0.75 vs. 1.11 bleeds per year), but joint bleeding rates were similar. Accordingly, the most pronounced reduction in ABR was seen among patients with inhibitors, whose ABR dropped from 5.08 to 0.75.
